Department of Otolaryngology Head and Neck Surgery, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, U.S.A.
Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.
Laryngoscope. 2021 May;131(5):E1468-E1475. doi: 10.1002/lary.29102. Epub 2020 Sep 18.
To evaluate the incidence of histopathologic diagnostic discrepancy for patients referred to our institution, identify pathologies susceptible to diagnostic error, and assess the impact on survival of histopathologic diagnostic discrepancies.
Three hundred ninety-seven patients with sinonasal cancers were identified, and discordance between the outside pathologic report and MD Anderson Cancer Center pathologic report was assessed. Overall survival and disease-specific survival were analyzed using Kaplan-Meier and log rank methods.
Discordance of major histopathologic diagnoses was present in 24% (97 of 397) of reports, with sinonasal undifferentiated carcinoma, sarcoma, neuroendocrine carcinoma, and poorly differentiated carcinoma pathologies having the highest change in diagnosis (P < .01). A further 61% (244 of 397) had minor changes such as histologic grade, subtype, or stage, with sarcoma and neuroendocrine carcinoma pathologies being most susceptible to change (P < .02). Overall, the 5-year overall survival (OS) and disease-specific survival (DSS) was reduced in patients with a major change in histopathologic diagnosis (59.2% vs. 70.2% (P = .02) and 72.9% vs. 81.2% (P = .02), respectively). Furthermore, patients with a major change in diagnosis and prior treatment experienced a significant reduction in 5-year OS (61.9% vs. 70.4%, P = .03 < .01) and DSS (72.4% vs. 81.5%, P = .04).
Histopathological diagnosis of sinonasal tumors is complex and challenging given the rarity of the disease. Obtaining the correct diagnosis is important for treatment selection and survival. In histologies prone to misdiagnoses, obtaining a second opinion from experienced head and neck pathologists at a high-volume institution may potentially lead to a change in treatment recommendations that could result in improved survival in patients with sinonasal malignancies.
4 Laryngoscope, 131:E1468-E1475, 2021.
评估我院患者的病理诊断差异发生率,确定易发生诊断错误的病理类型,并评估病理诊断差异对生存率的影响。
共纳入 397 例鼻窦癌患者,评估外部病理报告与 MD 安德森癌症中心病理报告之间的差异。使用 Kaplan-Meier 和对数秩检验分析总生存和疾病特异性生存。
24%(97/397)的报告存在主要组织病理学诊断差异,其中未分化鼻窦癌、肉瘤、神经内分泌癌和低分化癌的诊断改变最大(P<.01)。61%(244/397)的报告存在次要改变,如组织学分级、亚型或分期,肉瘤和神经内分泌癌最容易发生改变(P<.02)。总体而言,组织病理学诊断有重大改变的患者 5 年总生存率(OS)和疾病特异性生存率(DSS)降低(59.2%比 70.2%(P=.02)和 72.9%比 81.2%(P=.02))。此外,诊断和既往治疗有重大改变的患者 5 年 OS(61.9%比 70.4%,P=.03<.01)和 DSS(72.4%比 81.5%,P=.04)显著降低。
由于疾病罕见,鼻窦肿瘤的组织病理学诊断复杂且具有挑战性。获得正确的诊断对于治疗选择和生存至关重要。在易误诊的组织学中,在高容量机构获得经验丰富的头颈部病理学家的第二意见,可能会改变治疗建议,从而提高鼻窦恶性肿瘤患者的生存率。
4 级喉镜,131:E1468-E1475,2021。